Melbourne Genomics Health Alliance
This project has been completed.
The information below may be out of date,
and is provided for historical purposes only.
The Melbourne Genomics Health Alliance began as a pilot project in 2014, supported by $25m in funding from the Victorian Government from 2015-2018. It was intended that the Melbourne Genomics findings would contribute directly to future health practices and budgets, by determining where genomics has the most benefit to offer and how it might be applied across the Victorian hospital system. Involvement in further national and international efforts would ensure Australia’s health system benefits from those lessons, shared with colleagues within the Australian Genomics Health Alliance (AGHA) and globally through the World Genomics Health Alliance.
Melbourne Genomics was supported in the early phases by our clinical genomics experts who developed the necessary analysis pipelines for the work. In 2016 we produced a clinical-grade variant calling pipeline and variant curation database. These tools were deployed within accredited clinical laboratories within Victoria as GenoVic, and have been successfully used to complete the analysis of the first phase of project flagships. We also began analysing the next phase of the project flagships, with the inclusion of a new cancer analysis pipeline. As the project moved from the pilot phase to production, we participated in requirements analysis for the future State production platform and the review of candidate solutions.
Melbourne Bioinformatics experts who worked on this project include:
- A/Prof Bernie Pope (lead) (also working directly with AGHA)
- Gayle Philip
- Peter Georgeson
- Anthony Marty
- Juny Kesumadewi
- Michael Milton
- Mailie Gall (also working directly with AGHA)
- Ivo Fokkema (guest from Leiden University Medical Centre, Netherlands)
For more information, see Melbourne Genomics.